Results 241 to 250 of about 508,157 (387)

Whole‐genome sequencing of 1,083 HPV45 cases and controls identifies genetic variants associated with glandular cervical lesions

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Little is known about how genetic variation in human papillomavirus type 45 (HPV45) influences its ability to cause cancer. Here, the authors conducted the largest whole‐genome sequencing study to date of HPV45, looking for associations between viral genetic variation and precancer or cancer risk.
Aimee J. Koestler   +14 more
wiley   +1 more source

p16INK4a and HPV E4 immunohistochemistry for the prediction of regression of cervical intraepithelial neoplasia grade 2—A historical cohort study

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Immunohistochemical biomarkers are increasingly used for the grading of cervical intraepithelial neoplasia (CIN); however, their clinical utility in the prediction of CIN2 regression is largely unexplored. Here, the authors analyzed the risk of CIN2 regression in relation to p16INK4a and HPVE4 immunohistochemistry in a large cohort of women
Rikke Damgaard   +10 more
wiley   +1 more source

Randomised trial on treatment of vaginal high‐grade squamous intraepithelial lesion: Self‐administered vaginal imiquimod and laser vaporisation

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Vaginal high‐grade squamous intraepithelial lesions (HSILs), precursors of vaginal cancer that are related to human papillomavirus (HPV) infection, often are treated with laser vaporization. HSIL treated in this way, however, tends to recur.
Mari Kiviharju   +7 more
wiley   +1 more source

Mass cytometric detection of homologous recombination proficiency in circulating tumor cells to predict chemoresistance of metastatic breast cancer patients

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Circulating tumor cells can offer insights into treatment responses and metastatic recurrence, but current analysis methods are limited. Here, the authors tested a newly developed mass cytometry panel comprising biomarkers such as γH2AX and RAD51 in longitudinally monitored metastatic breast cancer patients.
Kathrin Niedermayer   +17 more
wiley   +1 more source

Acute obstetric coagulopathy: need for innovation. [PDF]

open access: yesBlood Adv
Chumappumkal Joseph B, von Drygalski A.
europepmc   +1 more source

A NEW OBSTETRIC FORCEPS. [PDF]

open access: green, 1896
A. B. SPÄCH
openalex   +1 more source

Home - About - Disclaimer - Privacy